Schedule 13G ownership disclosure

ADAMAS PHARMACEUTICALS INC

Security class unavailable · CUSIP: 00548A106

Event date: 2016-07-29

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
Unavailable
Percent of class
11.8300%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0000930413-17-000553
Form type
SC 13G/A
Filer
Adamas Pharmaceuticals Inc
CIK
CIK 1328143
Filed
Feb 14, 2017
Reporting period
Jul 29, 2016
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub